Protagenic Therapeutics, Inc.\new Fresh-Start Adjustment, Increase (Decrease), Preferred Stock
Protagenic Therapeutics, Inc.\new (PTIX) had Fresh-Start Adjustment, Increase (Decrease), Preferred Stock of $5.00 thousand as of 2013-07-11, per its 10-K filed 2015-09-25.
Discontinued › Notes
us-gaap:FreshStartAdjustmentIncreaseDecreasePreferredStock · last filed 2015-09-25
- 2013-07-11: Fresh-Start Adjustment, Increase (Decrease), Preferred Stock $5.00K.
| Period end | Fresh-Start Adjustment, Increase (Decrease), Preferred Stock |
|---|---|
| 2013-07-11 | $5.00K 10-K · filed 2015-09-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |